Original article
Gout and coronary heart disease: The framingham study

https://doi.org/10.1016/0895-4356(88)90127-8Get rights and content

Abstract

The relationship between gout, not associated with the use of diuretics, and the development of coronary heart disease was examined in 5209 subjects originally enrolled in the Framingham Study. Based on 32 years of follow-up, the two year incidence of gout was six times greater in men (3.2/1000) as compared to women (0.5/1000). For both sexes, the incidence of gout showed no clear relationship with age. Among men who never received diuretics, those afflicted by gout, as compared to those without gout, experienced a 60% excess of coronary heart disease (95% confidence limits, 1.1–2.2), primarily attributed to a two fold excess of angina pectoris (95% confidence limits, 1.2–3.1). Although gout was usually associated with other atherogenic risk factors, control of systolic blood pressure, total cholesterol, alcohol intake, body mass index, and diabetes failed to alter the effect of gout on the preceding coronary events in men. For women, there were no significant associations between gout and coronary heart disease. We conclude that gout, unrelated to the intake of diuretics, imparts an additional risk of coronary heart disease in men, unexplained by clinically measured risk factors.

References (39)

  • C.J. Bulpitt

    Serum uric acid in hypertensive patients

    Br Heart J

    (1975)
  • E. Bengtsson

    Elevated serum uric acid levels during treatment with antihypertensive drugs

    Acts Med Scand

    (1979)
  • B.G. Oren et al.

    Chlorthiazide (Diuril) as hyperuricemic agent

    JAMA

    (1958)
  • T.R. Dawber et al.

    An approach to longitudinal studies in a community: The Framingham Study

    Ann NY Acad Sci

    (1963)
  • P. Sorlie

    Cardiovascular Diseases and Death Following Myocardial Infarction and Angina Pectoris: Framingham Study, 20 year Follow-up

  • P.W. Lane et al.

    Analysis of covariance and standardization as instances of prediction

    Biometrics

    (1982)
  • D.R. Cox

    Regression models and life tables

    J R Stat Soc

    (1972)
  • R. Grahame et al.

    Clinical survey of 354 patients with gout

    Ann Rheum Dis

    (1970)
  • Cited by (299)

    • Managing Cardiovascular Risk in Patients with Rheumatic Disease

      2022, Rheumatic Disease Clinics of North America
    • Sesquiterpene lactones from Lychnophora species: Antinociceptive, anti-inflammatory, and antioxidant pathways to treat acute gout

      2021, Journal of Ethnopharmacology
      Citation Excerpt :

      Gout is an inflammatory arthritis that affects 1%–4% of the population in developed countries, particularly those in North America and Europe (Kuo et al., 2015). Its prevalence is higher in men over 75 years old (Smith et al., 2014), and it is strictly related to cardiovascular and renal diseases and to metabolic syndrome (Abbott et al., 1988; Puig and Martínez, 2008; Yu et al., 2012). Many studies focused on the discovery of new drugs to treat hyperuricemia and gout.

    • Α higher ratio of serum uric acid to serum creatinine could predict the risk of total and cause specific mortality- insight from a US national survey

      2021, International Journal of Cardiology
      Citation Excerpt :

      Hyperuricemia has been associated with increased BMI, dyslipidemia and HTN [33]. The Framingham study was the first to show an independent relation between SUA levels and the risk of cardiovascular outcomes in the general population during a 23-year follow up period [34]. The underlying mechanisms are still not elucidated; insulin resistance is regarded as the interlink between hyperuricemia and the development of metabolic disorders [30].

    View all citing articles on Scopus

    Supported in part by contracts NIH-NOI-HV-92922 and NIH-NOI-HV-52971.

    View full text